Virax Biolabs Announces Extraordinary General Meeting of Shareholders

PUBT · 20h ago
Virax Biolabs Announces Extraordinary General Meeting of Shareholders
  • Virax Biolabs will hold an extraordinary general meeting at BioCity Glasgow in Newhouse, Lanarkshire, on November 27, 2026.
  • Shareholders will vote on a 1-for-4 ordinary share consolidation, proposed to take effect December 14, 2026, or later.
  • A subsequent proposal would increase authorized share capital from US$12.5 million to US$50 million, creating 375,000,000 ordinary shares.
  • Related charter amendments would reflect the share consolidation and capital increase.
  • Shareholders will also consider allowing adjournment if votes are insufficient to pass the proposals.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Virax Biolabs Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-460710), on November 13, 2026, and is solely responsible for the information contained therein.